Platelet ‘decoys’ outsmart both clots and cancer

A team of researchers at the Wyss Institute at Harvard University and several collaborating institutions has created a drug-free, reversible antiplatelet therapy that uses deactivated “decoy” platelets to reduce the risk of blood clots and potentially prevent cancer metastasis.

Lindsay Brownell
Feb. 13, 2019 | harvard

~8 mins   

Tags: health-medicine activated-platelets antiplatelet-drugs blood-clots deactivated-platelets decoys tumors wyss-institute-at-harvard-university

Page 1 of 1